4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-20-070840
Chief Financial Officer bought 4,348 shares at $1.15 ($4,978)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Elefant Dov Chief Financial Officer | 2020-06-05 | Purchase | +4,348 | $1.15 | $4,978 | 4,348 | D |
| Derivatives | |||||||
| Elefant Dov Chief Financial Officer | 2020-06-05 | Purchase · Series H Warrants | +2,174 | $0.01 | $22 | 2,174 | D |
| Open-market purchases · 4,348 sh · avg $1.15 · $4,978 | |||||||
Loading xslF345X03/tm2022064d3_4.xml…